Michael A. Klobuchar - 30 Apr 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP - Chief Strategy Officer
Signature
/s/ Kelly E. W. Grez, attorney-in-fact for Michael Klobuchar
Issuer symbol
MRK
Transactions as of
30 Apr 2024
Transactions value $
$0
Form type
4
Date filed
02 May 2024, 16:09
Previous filing
16 Feb 2024
Next filing
02 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 23.2K 30 Apr 2024 Direct F1
holding MRK Common Stock 6.29 30 Apr 2024 By Child
holding MRK Common Stock 6.29 30 Apr 2024 By Child
holding MRK Common Stock - 401(k) Plan 867 30 Apr 2024 By 401(k) F2
holding MRK Common Stock - 401(k) Plan 697 30 Apr 2024 By Spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +20.5K $0.00 20.5K 30 Apr 2024 Common Stock 20.5K $129.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
F3 The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.